Pathology Inc. has been acquired by LabCorp
March 2016 – England Securities, LLC is pleased to announce that it served as the exclusive financial advisor to Pathology, Inc. in the sale of substantially all of its operating assets to Laboratory Corporation of America Holdings (LabCorp) (NYSE:LH). The acquisition includes Pathology, Inc.’s patient service centers used to conduct its medical testing and services businesses.
“Pathology, Inc. is a premier laboratory known for quality, science and innovation in women’s health testing,” said David P. King, chairman and chief executive officer of LabCorp. “It is an excellent fit with LabCorp’s existing women’s health service offerings and supports our mission to provide world class diagnostic solutions that improve health and improve lives.”
Pathology, Inc., a portfolio company of ABS Capital Partners, is the West Coast’s premier Women’s Health laboratory, with subspecialty expertise in anatomic, molecular and digital pathology. The company’s integrated diagnostic services help doctors personalize patient care to optimally treat disease and maintain health and wellness. Pathology, Inc. is a full-service laboratory offering both clinical and anatomic pathology testing, with nationally recognized pathology expertise in hematopathology, dermatopathology, cytopathology, genitourinary pathology, gynecology, and gastrointestinal pathology.